Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 8/20 | 0.60 |
| ▸ | HTR1B | P28222 | 6/20 | 0.60 |
| ▸ | HTR1A | P08908 | 14/20 | 0.51 |
| ▸ | HTR2C | P28335 | 11/20 | 0.51 |
| ▸ | HTR2A | P28223 | 4/20 | 0.51 |
| ▸ | HTR2B | P41595 | 3/20 | 0.51 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.51 |
| ▸ | HTR3B | O95264 | 2/20 | 0.51 |
| ▸ | HTR1E | P28566 | 2/20 | 0.51 |
| ▸ | HTR1F | P30939 | 2/20 | 0.51 |
| ▸ | HTR7 | P34969 | 2/20 | 0.51 |
| ▸ | HTR3A | P46098 | 2/20 | 0.51 |
| ▸ | HTR5A | P47898 | 2/20 | 0.51 |
| ▸ | HTR6 | P50406 | 2/20 | 0.51 |
| ▸ | HTR4 | Q13639 | 2/20 | 0.51 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.51 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.51 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8103630 | 0.80 | HTR1A (0.62) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL8104561 | 0.80 | HTR1A (0.61) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL8113709 | 0.80 | HTR1D (0.59) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL8113315 | 0.79 | HTR1D (0.64) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL8784258 | 0.77 | HTR1A (0.71) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL8112400 | 0.75 | HTR1A (0.59) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL7809973 | 0.75 | HTR1D (0.72) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL9274413 | 0.74 | HTR1D (0.60) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL8784256 | 0.73 | HTR1D (0.66) | HTR1DHTR1BHTR1AHTR2CHTR2A | |
| SCHEMBL8783766 | 0.71 | HTR1D (0.66) | HTR1DHTR1BHTR1AHTR2CHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0637307-B1 | IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES | MERCK SHARP & DOHME (GB) | 2000-11-08 | — | — | EP | claimed |
| US-5607957-A | CONTAINING ALSO INDOLE, BENZOFURAN, BENZTHIOPHENE OR INDAZOLE MOIETY; METHOD FOR TREATMENT AND/OR PREVENTION OF CLINICAL CONDITIONS FOR WHICH A SELECTIVE AGONIST OF 5-HT1-LIKE RECEPTORS IS INDICATED | MERCK SHARP & DOHME LTD. (GB) | 1997-03-04 | — | — | US | claimed |
| EP-0637307-A1 | IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES | MERCK SHARP & DOHME LTD. (GB) | 1995-02-08 | — | — | EP | claimed |
| WO-1993020066-A1 | IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES | MERCK SHARP & DOHME LIMITED (GB) | 1993-10-14 | — | — | WO | claimed |
| EP-0637307-B1 | IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES | MERCK SHARP & DOHME (GB) | 2000-11-08 | — | — | EP | disclosed |
| US-5607957-A | CONTAINING ALSO INDOLE, BENZOFURAN, BENZTHIOPHENE OR INDAZOLE MOIETY; METHOD FOR TREATMENT AND/OR PREVENTION OF CLINICAL CONDITIONS FOR WHICH A SELECTIVE AGONIST OF 5-HT1-LIKE RECEPTORS IS INDICATED | MERCK SHARP & DOHME LTD. (GB) | 1997-03-04 | — | — | US | disclosed |
| EP-0637307-A1 | IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES | MERCK SHARP & DOHME LTD. (GB) | 1995-02-08 | — | — | EP | disclosed |
| WO-1993020066-A1 | IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES | MERCK SHARP & DOHME LIMITED (GB) | 1993-10-14 | — | — | WO | disclosed |